6-Fluoro-4-oxochroman-2-carboxylic acid

Catalog No. :
ACRWKO870
CAS No. :
105300-40-1
Molecular Formula :
C10H7FO4
Molecular Weight :
210.16

IUPAC Name:6-fluoro-4-oxochromane-2-carboxylic acid

6-Fluoro-4-oxochroman-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$95.00Login to see priceIn stockInquiry
250mg95%$133.00Login to see priceIn stockInquiry
1g95%$330.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Fluoro-4-oxochroman-2-carboxylic acid
IUPAC Name6-fluoro-4-oxochromane-2-carboxylic acid
MDL No.MFCD03094353
Molecular FormulaC10H7FO4
Molecular Weight210.16
SMILESO=C(C1CC(C2=C(O1)C=CC(F)=C2)=O)O
InChI KeyBWXXHZKFLLLJQP-UHFFFAOYSA-N
Synonymrac-6-Fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic Acid;6-Fluoro-4-chroManone-2-carboxylic Acid;6-fluoro-4-oxo-3,4-dihydro-2H-chroMene-2-carboxylic acid;6-Fluoro-4-oxochroman-2-carboxylic acid;6-Fluoro-4-Oxo-3,4-Dihydro-2H_x0002_Chromane-2-Carboxylic Acid (NEBIVOLOL STEP-II);Nebivolol Impurity 43;2H-1-Benzopyran-2-carboxylic acid, 6-fluoro-3,4-dihydro-4-oxo-;6-Fluoro-4-Oxo-3,4-Dihydro-2H-Chromane-2-Carboxylic Acid (NEBIVOLOL STEP-II)
CAS No.105300-40-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRWKO870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMVDL849 route compound structure diagram
    ACMVDL84999199-59-4 In Stock
  2. Then
  3. ACRWKO870 route product structure diagram
    ACRWKO870105300-40-1 In Stock
Inquiry

2. ACRWKO870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWKO870 route product structure diagram
    ACRWKO870105300-40-1 In Stock
Inquiry

Comments (0)